Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Our common stock is traded on the NASDAQ Global Market, under the symbol KEQU. The following table sets forth the quarterly high and low prices reported on the NASDAQ Global Market for our stock over the last two fiscal years.
First
Quarter Second
Quarter Third
Quarter Fourth
Quarter
2021
High $11.10 $11.35 $13.45 $13.43
Low $8.50 $8.20 $8.08 $11.99
Close $9.52 $8.20 $13.20 $12.00
2020
High $23.00 $18.20 $19.57 $12.80
Low $16.18 $15.06 $12.30 $6.96
Close $18.25 $16.09 $12.56 $10.23
As of July 6, 2021, we estimate there were approximately 1,092 holders of our common shares, of which 126 were stockholders of record. We paid cash dividends per share of $0.38 for fiscal year 2020. On December 16, 2019, the Company announced that the Board of Directors had elected to suspend the Company's dividend. The declaration and payment of any future dividends will be at the discretion of the Board of Directors and will depend upon many factors, including the Company's earnings, capital requirements, investment and growth strategies, financial conditions, the terms of the Company's indebtedness, which currently contains provisions that could limit the payment of dividends in certain circumstances, and other factors that the Board of Directors may deem to be relevant.
SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS
See Item 12 , Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters , in this Form 10-K for a discussion of securities authorized for issuance under our equity compensation plans.
9
Table of Contents
Item 6. Selected Financial Data
The following tables set forth selected historical consolidated financial and other data for the periods indicated. The consolidated financial data should be read in conjunction with Item 8 , Financial Statements and Supplementary Data , and with Item 7 , Management's Discussion and Analysis of Financial Condition and Results of Operations .
Twelve Months Ended April 30,
$ and shares in thousands, except per share amounts 2021 2020
OPERATING STATEMENT DATA:
Net sales $ 147,469 $ 147,540
Cost of products sold 123,476 124,113
Gross profit 23,993 23,427
Operating expenses 25,309 25,772
Operating loss (1,316) (2,345)
Pension expense (1,153) (454)
Other income, net 241 426
Interest expense (389) (493)
Loss before income taxes (2,617) (2,866)
Income tax expense 990 1,758
Net loss (3,607) (4,624)
Less: net earnings attributable to non-controlling interest 65 63
Net loss attributable to Kewaunee Scientific Corporation $ (3,672) $ (4,687)
Weighted average shares outstanding:
Basic 2,760 2,750
Diluted 2,760 2,750
PER SHARE DATA:
Net loss attributable to Kewaunee Scientific Corporation stockholders
Basic $ (1.33) $ (1.70)
Diluted $ (1.33) $ (1.70)
Cash dividends $ — $ 0.38
Year-end book value $ 15.05 $ 13.97
As of April 30
$ in thousands 2021 2020
BALANCE SHEET DATA:
Current assets $ 60,457 $ 54,231
Current liabilities 34,181 27,060
Net working capital 26,276 27,171
Net property, plant and equipment 15,982 16,272
Total assets 89,384 83,929
Total borrowings/long-term debt 16,148 13,913
Kewaunee Scientific Corporation stockholders' equity 41,241 38,415
OTHER DATA:
Capital expenditures $ 2,397 $ 2,465
Year-end stockholders of record 125 125
Year-end full-time employees (Domestic) 543 623
Year-end full-time employees (International) 295 289
10
Table of Contents